IRVINE, Calif. – May 8, 2019 – AIVITA Biomedical today announced that it will be exhibiting at two upcoming conferences in May for skincare and regenerative medicine. May 9-11 AIVITA will be exhibiting its skincare products at Music City Symposium for Cosmetic Advances & Laser Education (SCALE) in Nashville, Tennessee. May 15-17 AIVITA CEO Dr. Hans Keirstead will speak at the 14^th World Advanced Therapies and Regenerative Medicine Congress in London, England.

SCALE caters to licensed physicians and their staff, providing the latest medical education and technology demonstrations for dermatologists and cosmetic surgeons. AIVITA will be exhibiting its ROOT of SKIN™ MD line of rejuvenating skincare products, containing its proprietary active SourceCode Technology™.

The 14^th World Advanced Therapies & Regenerative Medicine Congress is an annual meeting that covers the latest advancements in regenerative medicine. Dr. Keirstead will speak Thursday, May 16 at 3:45 PM GMT, delivering a talk titled “Clinical and Commercial Application of Scaled Human Stem Cell Derivates in Immune-Oncology.”

About ROOT of SKIN™

ROOT of SKIN™ is a rejuvenating line of skincare products fueled by an unrelenting pursuit for advancements in life-changing and life-saving treatments. Harnessing breakthroughs in stem cell therapy, AIVITA Biomedical developed a technology that does more than just boost regeneration. The patented actives complex SourceCode Technology™ renews, repairs and protects, just as your skin did at its youngest and healthiest stage. Rich with every biological component healthy skin needs for development, and free of any unnecessary ingredients. All proceeds support the treatment of women with ovarian cancer.

About AIVITA Biomedical

AIVITA Biomedical is a privately held company engaged in the advancement of commercial and clinical-stage programs utilizing curative and regenerative medicines. Founded in 2016 by pioneers in the stem cell industry, AIVITA Biomedical utilizes its expertise in stem cell growth and directed, high-purity differentiation to enable safe, efficient and economical manufacturing systems which support its therapeutic pipeline and commercial line of skin care products.

###